ScholarIQanswers from OpenAlex

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis

PaperCitations, authors & open-access status

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis have?

ScholarIQcitation count

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis has 256 citations in the OpenAlex counts ScholarIQ stores.

When was A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis published?

ScholarIQyear

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis has 2017 year in the ScholarIQ index.

What is the open-access status of A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis?

ScholarIQoa status

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis has closed oa status in the ScholarIQ index.

What is the DOI of A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis?

ScholarIQdoi

The DOI for A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis is on the source record.

What is the PMID of A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis?

ScholarIQpmid

The PMID for A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis is on the source record.

What is the OpenAlex record for A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis?

ScholarIQopenalex

The OpenAlex for A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial